Other less common cancers that have high rates of KRAS mutations include appendiceal mucinous adenocarcinomas with rates of 60–80% and ovarian mucinous carcinomas with rates of 64% [17]. This evidence concerns the gene KRAS and colon mucinous adenocarcinoma.